Chai Discovery stock
Private-market facts for current and former Chai Discovery employees researching their stock.
Overview
Chai Discovery develops open-source AI models for molecular structure prediction and drug discovery, with its Chai-1 model predicting protein, DNA, RNA, and small molecule structures.
Selling Chai Discovery shares
Why shareholders consider selling
Shareholders in Chai Discovery may explore liquidity for a number of reasons — diversifying a concentrated position, funding a personal financial goal, or simply reducing exposure to a single private holding. As a private company, Chai Discovery does not trade on a public exchange, meaning employees and early shareholders cannot simply sell through a brokerage. Extended private timelines can leave shareholders waiting years for an exit event, which is why some choose to explore secondary-market options.
Can you sell Chai Discovery stock?
Whether a shareholder can sell typically depends on what they hold and how it was acquired. Vested and exercised shares are generally more straightforward than unexercised options or unvested RSUs. Most private companies, including those in the Healthcare & Biotech sector, impose transfer restrictions such as rights of first refusal or board approval requirements. The specific terms governing Chai Discovery shares would be outlined in the holder's equity agreement or the company's governing documents.
What affects the value of Chai Discovery shares?
The price a buyer is willing to pay for private shares is shaped by several factors: overall demand for the stock, the company's financial performance, broader Healthcare & Biotech market conditions, and any recent private-market transaction activity. Data points such as the company's Series A round and its reported $1B valuation can help frame expectations, though they do not guarantee a transaction price.
What should holders check before selling
- The type of security held (common shares, preferred, options, RSUs)
- Whether the equity is fully vested and, for options, whether it has been exercised
- Any transfer restrictions, lock-up provisions, or company approval requirements
- Estimated net proceeds after applicable taxes and transaction fees
- Whether partial liquidity — selling a portion rather than the full position — may be a better fit
Tools for Chai Discovery shareholders
Exploring equity in Chai Discovery often raises questions about taxes, exercise timing, valuation, and exit outcomes. These tools can help you model different decisions using your own assumptions.
Latest funding round
Chai Discovery most recently raised a Series A round in June 2024. The company was valued at $1B. Total funding raised to date is approximately $130M.
Lead investors in this round include Thrive Capital.
Founders & company background
Chai Discovery was founded in 2024 by Joshua Meier and is headquartered in San Francisco, CA.
Investors
Industry
Similar private companies
Latest Chai Discovery news
Frequently asked questions
- Is Chai Discovery still a private company?
- Yes, Chai Discovery is currently a private company.
- What is Chai Discovery's latest funding round?
- Chai Discovery's most recent known round is Series A, raised in June 2024.
- What is Chai Discovery's valuation?
- Chai Discovery's latest reported valuation is $1B.
- Who are the investors in Chai Discovery?
- Notable investors include Thrive Capital.
- Can I sell my Chai Discovery stock?
- Private company shares can sometimes be sold on secondary markets. Speaking with a specialist who understands Chai Discovery stock can help you evaluate your options.
Related pages
Last verified: 2026-04-13 · Chai Discovery data compiled from funding disclosures, investor announcements, corporate filings, and public records.
Information on this page is compiled from publicly available sources and may be outdated or incomplete. This is not investment advice. Consult a qualified advisor before making financial decisions.